Browsing Archive: Jim Lang | EVERSANA

Posted on January 10, 20211/10/21

Humanigen and EVERSANA Announce Partnership to Support the Launch and Commercialization of Lenzilumab for the Treatment of COVID-19

Posted on November 30, 202011/30/20

MacroGenics and EVERSANA Announce Agreement to Support the Potential Launch and Commercialization of Margetuximab

Posted on November 12, 202011/12/20

EVERSANA announces strategic partnership with Roivant Sciences to advance commercialization services and predictive analytics for healthcare

Posted on November 9, 202011/9/20

EVERSANA announces broad-scale strategic partnerships with industry leaders in claims, EMR, formulary and provider-institutional data to optimize real-time commercial services

Posted on November 5, 202011/5/20

EVERSANA™ named a Great Place to Work by global workplace authority for second consecutive year

Posted on October 26, 202010/26/20

Evoke and EVERSANA Announce Commercial Launch of Gimoti™

Posted on October 15, 202010/15/20

Mirum Pharmaceuticals Announces Partnership With EVERSANA to Support Launch and Commercialization of Maralixibat for Alagille Syndrome in the United States

Posted on September 28, 20209/28/20

Palette Life Sciences Announces Partnership Agreement With EVERSANA to Support US Commercialization of Solesta™

Posted on September 16, 20209/16/20

EVERSANA launches ACTICS by EVERSANA™, the technology-enabled solution combining predictive analytics integrated with real-time commercial services to drive next best action in the life science sector

Posted on September 9, 20209/9/20

EVERSANA™ expands pharmaceutical training and digital engagement capabilities with acquisition of Alkemy Partners